The selective delivery of bromodomain-containing protein 4 (BRD4) siRNA to AML cells was achieved by targeting the surface antigen CD123 and resulted in downregulation of mRNA and increased apoptosis of leukemic cells [88]. This evidence concerns the gene BRD4 and acute myeloid leukemia.